The Center for International Blood and Marrow Transplant Research (CIBMTR) is a clinical research program dedicated to addressing important issues in the field of hematopoietic cell transplantation (HCT). CIBMTR maintains a large outcomes registry with information for more than 330,000 HCT recipients in over 300 centers and provides statistical support for analyzing those data. A separately funded Research Repository of donor-recipient specimens linked to these clinical data is available for a large subset of patients. Use of this Resource by hundreds of investigators around the world during the current and previous funding cycles have contributed to >700 publications on important issues and to improved global collaboration in data exchange and HCT research. With continuation of U24-CA76518, CIBMTR will continue to build on the infrastructure made possible by this support to facilitate in-depth exploration of clinical, immunogenetic, quality of life, and health services issues related to HCT. This application proposes to enhance this Resource and to advance its utility through the following Specific Aims: Resource Development: Provide the biomedical community a high-quality clinical database and state-of-the-art statistical support to address important issues in HCT and related fields through continued enhancement of data collection and management technology and procedures, expansion of the Resource to include patient-reported outcomes, gathering and disseminating data necessary for health services research and data on some non-HCT patients, development and application of novel statistical techniques, and collaboration with national and international networks in HCT and related fields. Resource Utilization: Increase use of data and statistical resources maintained by the CIBMTR to support studies with important clinical and policy implications, and enhance Working and Advisory Committee and Statistical Center processes to prioritize and complete these studies.

Public Health Relevance

The CIBMTR continues to play a unique and important role in facilitating clinical research in HCT. It is committed to developing its research database and statistical capabilities to meet the needs of investigators in a rapidly evolving field. It will buld on the infrastructure made possible by support from U24-CA76518 and its partnerships to better serve the research and medical community and address important issues in HCT.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA076518-20
Application #
9250087
Study Section
Special Emphasis Panel (ZCA1-SRLB-V (J1))
Program Officer
Merritt, William D
Project Start
1998-03-01
Project End
2018-02-28
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
20
Fiscal Year
2017
Total Cost
$2,961,237
Indirect Cost
$478,039
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Horowitz, Mary; Schreiber, Hans; Elder, Alex et al. (2018) Epidemiology and biology of relapse after stem cell transplantation. Bone Marrow Transplant 53:1379-1389
Duncan, Christine N; Brazauskas, Ruta; Huang, Jiaxing et al. (2018) Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 53:1278-1287
Nikiforow, Sarah; Wang, Tao; Hemmer, Michael et al. (2018) Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated. Haematologica 103:1708-1719
Wang, Youjin; Zhou, Weiyin; Alter, Blanche P et al. (2018) Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia. Biol Blood Marrow Transplant 24:2003-2008
Buturovic, Ljubomir; Shelton, Jason; Spellman, Stephen R et al. (2018) Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection. Biol Blood Marrow Transplant 24:1299-1306
Arrieta-BolaƱos, Esteban; Crivello, Pietro; Shaw, Bronwen E et al. (2018) In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance. Blood Adv 2:1773-1783
D'Souza, Anita; Millard, Heather; Knight, Jennifer et al. (2018) Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 53:1079-1082
Bejanyan, Nelli; Zhang, Mei-Jie; Wang, Hai-Lin et al. (2018) Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. Biol Blood Marrow Transplant 24:945-955
Bhatt, Neel S; Brazauskas, Ruta; Tecca, Heather R et al. (2018) Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation. J Pediatr Hematol Oncol :
Wang, Yanzhi; Logan, Brent R (2018) Testing for center effects on survival and competing risks outcomes using pseudo-value regression. Lifetime Data Anal :

Showing the most recent 10 out of 641 publications